1.Perioperative rare adverse reactions discovery:real-world data foundations and methodological advances
Xuan YIN ; Ruijian HUANG ; Siyu KONG ; Jifang ZHOU
Chinese Journal of Pharmacoepidemiology 2025;34(8):917-925
Perioperative drug-related rare adverse reactions are often characterized by acute onset,high risk,and unpredictable,involving complex physiological and genetic factors.Currently,most perioperative pharmacovigilance relies on clinical monitoring and real-time data reporting by medical teams.However,due to scattered data and the masking of symptoms by anesthetics and pain medications,it is difficult to predict rare adverse reactions accurately and promptly.This paper systematically reviews the latest advancements in the integration of digital and intelligent technologies across various fields.Based on real-world data,our research team had leveraged digital-intelligence fusion technologies to deeply integrate big data with artificial intelligence,thereby constructing a standardized anesthesia-specific database.This enabled dynamic monitoring of vital signs,individualized risk prediction,and comprehensive analysis of multimodal data in real-world studies,providing an innovative solution for perioperative pharmacovigilance.The aim of this paper is to enhance the personalization and intelligence of perioperative drug safety management,thereby offering more effective protection for patient medication safety during the perioperative period.
2.The Impact of New-onset Heart Conduction Blocks After Transcatheter Aortic Valve Replacement on the Heart Conduction at 1-year Follow-up
Jifang MA ; You ZHOU ; Xiaobiao ZANG ; Weifeng SONG ; Ke CHEN ; Zhihan ZHAO ; Xianqing WANG ; Yonghui ZHAO ; Haixia FU
Chinese Circulation Journal 2025;40(2):164-169
Objectives:This study aims to explore the impact of new-onset heart conduction block post transcatheter aortic valve replacement(TAVR)on the cardiac conduction status during 1-year follow-up.Methods:A total of 130 patients who completed TAVR surgery at Fuwai Central-China Cardiovascular Hospital from July 2019 to October 2022 were screened.Among them,56 cases with postoperative heart conduction block were selected for analysis.According to the degree of heart block,patients were divided into mild block group(n=36),moderate block group(n=9),and severe block group(n=11).The clinical characteristics and cardiac conduction conditions at 1-year follow-up between different groups were compared.Results:During a mean(8.5±4.1)months follow-up period,10(17.9%)patients had long-term atrioventricular conduction block,and 46(82.1%)patients had partial or complete recovery of heart block,with 28(50.0%)patients with completely recovered cardiac conduction.In the mild block group,22(61.1%)cases were completely recovered,9(25.0%)patients partly recovered,and 5(13.9%)cases uncovered.In the moderate block group,2(22.2%)cases were completely recovered,5(55.6%)patients partly recovered,and 2(22.2%)cases uncovered.Difference in long-term atrioventricular conduction block among three groups was statistically significant(P<0.001).The Kaplan-Meier curve shows that patients with moderate to severe heart block have a higher rate of long-term atrioventricular conduction block(86.1%vs.77.8%vs.72.7%,log-rank P=0.03).Cox multivariate analysis exhibited that old age(≥75 years old,HR=1.204,95%CI:1.051-1.525,P=0.041)and severe heart conduction block(HR=1.106,95%CI:1.100-1.616,P=0.031)are the two independent risk factors for long-term atrioventricular conduction block post TAVR.Conclusions:The ratio of complete cardiac conduction recovery post TAVR is 50.0%.Older age(≥75 year)and new-onset severe heart conduction block are independent risk factors for long-term atrioventricular conduction block post TAVR procedure.
3.The Initial Evaluation of the Safety and Impact on Cardiac Electrical Synchronization Post Low Ventricular Septum Implantation of Leadless Pacemaker
Jifang MA ; You ZHOU ; Yonghui ZHAO ; Haitao YANG ; Xiaobiao ZANG ; Juan HU ; Weifeng SONG ; Xianqing WANG ; Haixia FU
Chinese Circulation Journal 2025;40(1):69-75
Objective:This study aims to investigate the feasibility and safety of implanting leadless pacemakers in the low septum and its impact on cardiac electrical synchronization.Methods:A total of 36 patients who received leadless pacemaker implantation at Fuwai Central China Cardiovascular Hospital from January 2021 to August 2023 were included in this study.According to implantation sites of leadless pacemakers,patients were divided into mid-septal group(n=16)and low-septal group(n=20).The clinical characteristics and cardiac electrical synchronization were compared between the two groups.Results:There were 21 male patients,mean age was(68±13)years old.There was no statistical difference in the type of brady-arrhythmia between the two groups(P=0.73).There were 61 implant attempts in these 36 patients,and there was no significant difference in the number of attempts,procedure time,and pacemaker parameters between the two groups,but the average procedure time tended to be shorter in the low-septal group([84±37]minutes vs.[105±35]minutes,P=0.09).In terms of electrical synchronization,there was no statistical difference in QRS duration between the low-septal group and the mid-septal group([162.0±21.1]ms vs.[174.0±14.8]ms,P=0.20).There were no vascular puncture complications,cardiac perforation,or pericardial tamponade during the procedure.There were no complications and readmissions related to the leadless pacemaker during follow-up period.Conclusions:Our results show that the implantation of a leadless pacemaker in the low ventricular septum is safe and effective,has a similar impact on cardiac electrical synchronization as mid-septal pacing.
4.Application and effect evaluation of transcranial direct current stimulation in the rehabilitation of swallowing function in stroke patients
Jingjing LI ; Jifang QIU ; Peihua ZHOU ; Qianqian ZENG ; Hanyin HU
China Modern Doctor 2025;63(4):44-47
Objective To explore the effect of transcranial direct current stimulation(tDCS)in rehabilitation of swallowing function in stroke patients.Methods A total of 86 stroke patients diagnosed and treated in Affiliated Rehabilitation Hospital of Zhejiang Chinese Medical University from December 2022 to December 2023 were selected as study objects,and they were divided into observation group and control group according to random number table method,with 43 cases in each group.The control group received routine rehabilitation programs,while the observation group received tDCS therapy on the basis of control group.The swallowing function,actual swallowing process and quality of life of two groups were compared before and after intervention.Results After the intervention,standardized swallowing assessment scores of observation group were significantly lower than those of control group(P<0.05).The scores of oral and pharyngeal phases of observation group were higher than those of control group(P<0.05),and there was no significant difference in esophageal phase score between two groups(P>0.05).The quality of life score of observation group was significantly higher than that of control group(P<0.05).Conclusion tDCS can improve the swallowing function of stroke patients and improve the quality of life,which is worthy of clinical application.
5.Perioperative rare adverse reactions discovery:real-world data foundations and methodological advances
Xuan YIN ; Ruijian HUANG ; Siyu KONG ; Jifang ZHOU
Chinese Journal of Pharmacoepidemiology 2025;34(8):917-925
Perioperative drug-related rare adverse reactions are often characterized by acute onset,high risk,and unpredictable,involving complex physiological and genetic factors.Currently,most perioperative pharmacovigilance relies on clinical monitoring and real-time data reporting by medical teams.However,due to scattered data and the masking of symptoms by anesthetics and pain medications,it is difficult to predict rare adverse reactions accurately and promptly.This paper systematically reviews the latest advancements in the integration of digital and intelligent technologies across various fields.Based on real-world data,our research team had leveraged digital-intelligence fusion technologies to deeply integrate big data with artificial intelligence,thereby constructing a standardized anesthesia-specific database.This enabled dynamic monitoring of vital signs,individualized risk prediction,and comprehensive analysis of multimodal data in real-world studies,providing an innovative solution for perioperative pharmacovigilance.The aim of this paper is to enhance the personalization and intelligence of perioperative drug safety management,thereby offering more effective protection for patient medication safety during the perioperative period.
6.Application and effect evaluation of transcranial direct current stimulation in the rehabilitation of swallowing function in stroke patients
Jingjing LI ; Jifang QIU ; Peihua ZHOU ; Qianqian ZENG ; Hanyin HU
China Modern Doctor 2025;63(4):44-47
Objective To explore the effect of transcranial direct current stimulation(tDCS)in rehabilitation of swallowing function in stroke patients.Methods A total of 86 stroke patients diagnosed and treated in Affiliated Rehabilitation Hospital of Zhejiang Chinese Medical University from December 2022 to December 2023 were selected as study objects,and they were divided into observation group and control group according to random number table method,with 43 cases in each group.The control group received routine rehabilitation programs,while the observation group received tDCS therapy on the basis of control group.The swallowing function,actual swallowing process and quality of life of two groups were compared before and after intervention.Results After the intervention,standardized swallowing assessment scores of observation group were significantly lower than those of control group(P<0.05).The scores of oral and pharyngeal phases of observation group were higher than those of control group(P<0.05),and there was no significant difference in esophageal phase score between two groups(P>0.05).The quality of life score of observation group was significantly higher than that of control group(P<0.05).Conclusion tDCS can improve the swallowing function of stroke patients and improve the quality of life,which is worthy of clinical application.
7.The Initial Evaluation of the Safety and Impact on Cardiac Electrical Synchronization Post Low Ventricular Septum Implantation of Leadless Pacemaker
Jifang MA ; You ZHOU ; Yonghui ZHAO ; Haitao YANG ; Xiaobiao ZANG ; Juan HU ; Weifeng SONG ; Xianqing WANG ; Haixia FU
Chinese Circulation Journal 2025;40(1):69-75
Objective:This study aims to investigate the feasibility and safety of implanting leadless pacemakers in the low septum and its impact on cardiac electrical synchronization.Methods:A total of 36 patients who received leadless pacemaker implantation at Fuwai Central China Cardiovascular Hospital from January 2021 to August 2023 were included in this study.According to implantation sites of leadless pacemakers,patients were divided into mid-septal group(n=16)and low-septal group(n=20).The clinical characteristics and cardiac electrical synchronization were compared between the two groups.Results:There were 21 male patients,mean age was(68±13)years old.There was no statistical difference in the type of brady-arrhythmia between the two groups(P=0.73).There were 61 implant attempts in these 36 patients,and there was no significant difference in the number of attempts,procedure time,and pacemaker parameters between the two groups,but the average procedure time tended to be shorter in the low-septal group([84±37]minutes vs.[105±35]minutes,P=0.09).In terms of electrical synchronization,there was no statistical difference in QRS duration between the low-septal group and the mid-septal group([162.0±21.1]ms vs.[174.0±14.8]ms,P=0.20).There were no vascular puncture complications,cardiac perforation,or pericardial tamponade during the procedure.There were no complications and readmissions related to the leadless pacemaker during follow-up period.Conclusions:Our results show that the implantation of a leadless pacemaker in the low ventricular septum is safe and effective,has a similar impact on cardiac electrical synchronization as mid-septal pacing.
8.The Impact of New-onset Heart Conduction Blocks After Transcatheter Aortic Valve Replacement on the Heart Conduction at 1-year Follow-up
Jifang MA ; You ZHOU ; Xiaobiao ZANG ; Weifeng SONG ; Ke CHEN ; Zhihan ZHAO ; Xianqing WANG ; Yonghui ZHAO ; Haixia FU
Chinese Circulation Journal 2025;40(2):164-169
Objectives:This study aims to explore the impact of new-onset heart conduction block post transcatheter aortic valve replacement(TAVR)on the cardiac conduction status during 1-year follow-up.Methods:A total of 130 patients who completed TAVR surgery at Fuwai Central-China Cardiovascular Hospital from July 2019 to October 2022 were screened.Among them,56 cases with postoperative heart conduction block were selected for analysis.According to the degree of heart block,patients were divided into mild block group(n=36),moderate block group(n=9),and severe block group(n=11).The clinical characteristics and cardiac conduction conditions at 1-year follow-up between different groups were compared.Results:During a mean(8.5±4.1)months follow-up period,10(17.9%)patients had long-term atrioventricular conduction block,and 46(82.1%)patients had partial or complete recovery of heart block,with 28(50.0%)patients with completely recovered cardiac conduction.In the mild block group,22(61.1%)cases were completely recovered,9(25.0%)patients partly recovered,and 5(13.9%)cases uncovered.In the moderate block group,2(22.2%)cases were completely recovered,5(55.6%)patients partly recovered,and 2(22.2%)cases uncovered.Difference in long-term atrioventricular conduction block among three groups was statistically significant(P<0.001).The Kaplan-Meier curve shows that patients with moderate to severe heart block have a higher rate of long-term atrioventricular conduction block(86.1%vs.77.8%vs.72.7%,log-rank P=0.03).Cox multivariate analysis exhibited that old age(≥75 years old,HR=1.204,95%CI:1.051-1.525,P=0.041)and severe heart conduction block(HR=1.106,95%CI:1.100-1.616,P=0.031)are the two independent risk factors for long-term atrioventricular conduction block post TAVR.Conclusions:The ratio of complete cardiac conduction recovery post TAVR is 50.0%.Older age(≥75 year)and new-onset severe heart conduction block are independent risk factors for long-term atrioventricular conduction block post TAVR procedure.
9.Expert consensus on antiviral therapy of COVID-19
Fujie ZHANG ; Zhuo WANG ; Quanhong WANG ; Qing MAO ; Jinsong BAI ; Hanhui YE ; Jia TIAN ; Tianxin XIANG ; Jihong AN ; Zujiang YU ; Wenjie YANG ; Xingxiang YANG ; Xiaoju ZHANG ; Jie ZHANG ; Lina ZHANG ; Xingwang LI ; Jiabin LI ; Manxiang LI ; Zhiwei LI ; Hourong ZHOU ; Yi SHI ; Xiaoling XU ; Xiaoping TANG ; Hong TANG ; Xixin YAN ; Wenxiang HUANG ; Chaolin HUANG ; Liang DONG ; Baosong XIE ; Jiandong JIANG ; Bin XIONG ; Xuemei WEI ; Jifang SHENG ; Ronghua JIN
Chinese Journal of Clinical Infectious Diseases 2023;16(1):10-20
COVID-19 is caused by a novel coronavirus-severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), which has being spreading around the world, posing a serious threat to human health and lives. Neutralizing antibodies and small molecule inhibitors for virus replication cycle are the main antiviral treatment for novel coronavirus recommended in China. To further promote the rational use of antiviral therapy in clinical practice, the National Center for Infectious Diseases (Beijing Ditan Hospital Capital Medical University and the First Affiliated Hospital, Zhejiang University School of Medicine) invited experts in fields of infectious diseases, respiratory and intensive care to develop an Expert Consensus on Antiviral Therapy of COVID-19 based on the Diagnosis and Treatment Guideline for COVID-19 ( trial version 10) and experiences in the diagnosis and treatment of COVID-19 in China. The consensus is concise, practical and highly operable, hopefully it would improve the understanding of antiviral therapy for clinicians and provide suggestions for standardized medication in treatment of COVID-19.
10.Management of corona virus disease-19 (COVID-19): the Zhejiang experience.
Kaijin XU ; Hongliu CAI ; Yihong SHEN ; Qin NI ; Yu CHEN ; Shaohua HU ; Jianping LI ; Huafen WANG ; Liang YU ; He HUANG ; Yunqing QIU ; Guoqing WEI ; Qiang FANG ; Jianying ZHOU ; Jifang SHENG ; Tingbo LIANG ; Lanjuan LI
Journal of Zhejiang University. Medical sciences 2020;49(1):0-0
The current epidemic situation of corona virus disease-19 (COVID-19) still remained severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Zhejiang University School of Medicine is the primary medical care center for COVID-19 inZhejiang Province. Based on the present expert consensus carried out by National Health Commission and National Administration of Traditional Chinese Medicine, our team summarized and established an effective treatment strategy centered on "Four-Anti and Two-Balance" for clinical practice. The "Four-Anti and Two-Balance"strategy included antivirus, anti-shock, anti-hyoxemia, anti-secondary infection, and maintaining of water, electrolyte and acid base balance and microecological balance. Meanwhile, integrated multidisciplinarypersonalized treatment was recommended to improve therapeutic effect. The importance of early viralogical detection, dynamic monitoring of inflammatory indexes and chest radiograph was emphasized in clinical decision-making. Sputum was observed with the highest positive rate of RT-PCR results. Viral nucleic acids could be detected in10% patients'blood samples at acute periodand 50% of patients had positive RT-PCR results in their feces. We also isolated alive viral strains from feces, indicating potential infectiousness of feces.Dynamic cytokine detection was necessary to timely identifyingcytokine storms and application of artificial liver blood purification system. The "Four-Anti and Two-Balance"strategyeffectively increased cure rate and reduced mortality. Early antiviral treatment could alleviate disease severity and prevent illness progression, and we found lopinavir/ritonavir combined with abidol showed antiviraleffects in COVID-19. Shock and hypoxemia were usually caused by cytokine storms. The artificial liver blood purification system could rapidly remove inflammatory mediators and block cytokine storm.Moreover, it also favoredthe balance of fluid, electrolyte and acid-base and thus improved treatment efficacy in critical illness. For cases of severe illness, early and also short periods of moderate glucocorticoid was supported. Patients with oxygenation index below 200 mmHg should be transferred to intensive medical center. Conservative oxygen therapy was preferred and noninvasive ventilation was not recommended. Patients with mechanical ventilation should be strictly supervised with cluster ventilator-associated pneumonia prevention strategies. Antimicrobial prophylaxis should be prescribed rationally and was not recommended except for patients with long course of disease, repeated fever and elevated procalcitonin (PCT), meanwhile secondary fungal infection should be concerned.Some patients with COVID-19 showed intestinal microbialdysbiosis with decreasedprobiotics such as and . Nutritional and gastrointestinal function should be assessed for all patients.Nutritional support and application of prebiotics or probiotics were suggested to regulate the balance of intestinal microbiota and reduce the risk of secondary infection due to bacterial translocation. Anxiety and fear were common in patients with COVID-19. Therefore, we established dynamic assessment and warning for psychological crisis. We also integrated Chinese medicine in treatment to promote disease rehabilitation through classification methods of traditional Chinese medicine. We optimized nursing process for severe patients to promote their rehabilitation. It remained unclear about viral clearance pattern after the SARS-CoV-2 infection. Therefore, two weeks' quarantine for discharged patients was required and a regular following up was also needed.The Zhejiang experience above and suggestions have been implemented in our center and achieved good results. However, since COVID-19 was a newly emerging disease, more work was warranted to improve strategies of prevention, diagnosis and treatment for COVID-19.

Result Analysis
Print
Save
E-mail